Biochemical Pharmacology,
Journal Year:
2024,
Volume and Issue:
226, P. 116410 - 116410
Published: July 3, 2024
Elevated
homocysteine
(Hcy)
levels
are
detrimental
to
neuronal
cells
and
contribute
cognitive
dysfunction
in
rats.
Mitochondria
plays
a
crucial
role
cellular
energy
metabolism.
Interestingly,
the
damaging
effects
of
Hcy
vivo
vitro
conditions
exhibit
distinct
results.
Herein,
we
aimed
investigate
on
mitochondrial
function
primary
neurons
PC12
explore
underlying
mechanisms
involved.
The
metabolic
intermediates
act
as
methyl
donors
play
important
epigenetic
regulatory
roles.
N6-methyldeoxyadenosine
(6
mA)
modification,
which
is
enriched
DNA
(mtDNA),
can
be
mediated
by
methylase
METTL4.
Our
study
suggested
that
perturbation
caused
may
attributable
mtDNA
6
mA
modification
difference.
could
activate
expression
METTL4
within
mitochondria
facilitate
status,
repress
transcription,
then
result
dysfunction.
The EPMA Journal,
Journal Year:
2024,
Volume and Issue:
15(2), P. 163 - 205
Published: April 18, 2024
Despite
their
subordination
in
humans,
to
a
great
extent,
mitochondria
maintain
independent
status
but
tightly
cooperate
with
the
"host"
on
protecting
joint
life
quality
and
minimizing
health
risks.
Under
oxidative
stress
conditions,
healthy
promptly
increase
mitophagy
level
remove
damaged
"fellows"
rejuvenating
mitochondrial
population
sending
fragments
of
mtDNA
as
SOS
signals
all
systems
human
body.
As
long
metabolic
pathways
are
under
systemic
control
well-concerted
together,
adaptive
mechanisms
become
triggered
increasing
protection,
activating
antioxidant
defense
repair
machinery.
Contextually,
attributes
patho-/physiology
instrumental
for
predictive
medical
approach
cost-effective
treatments
tailored
individualized
patient
profiles
primary
(to
protect
vulnerable
individuals
again
health-to-disease
transition)
secondary
affected
disease
progression)
care.
Nutraceuticals
naturally
occurring
bioactive
compounds
demonstrating
health-promoting,
illness-preventing,
other
health-related
benefits.
Keeping
mind
health-promoting
properties
nutraceuticals
along
therapeutic
potential
safety
profile,
there
is
permanently
growing
demand
application
mitochondria-relevant
nutraceuticals.
Application
beneficial
only
if
meeting
needs
at
individual
level.
Therefore,
risk
assessment
creation
pivotal
importance
followed
by
adapted
nutraceutical
sets
needs.
Based
scientific
evidence
available
nutraceuticals,
this
article
presents
examples
frequent
which
require
protective
measures
targeted
holistic
following
advanced
concepts
predictive,
preventive,
personalized
medicine
(PPPM/3PM)
Journal of Advanced Research,
Journal Year:
2024,
Volume and Issue:
65, P. 297 - 327
Published: May 14, 2024
Autophagy
is
an
evolutionarily
conserved
turnover
process
for
intracellular
substances
in
eukaryotes,
relying
on
lysosomal
(in
animals)
or
vacuolar
yeast
and
plants)
mechanisms.
In
the
past
two
decades,
emerging
evidence
suggests
that,
under
specific
conditions,
autophagy
can
target
particular
macromolecules
organelles
degradation,
a
termed
selective
autophagy.
Recently,
accumulating
studies
have
demonstrated
that
abnormality
of
closely
associated
with
occurrence
progression
many
human
diseases,
including
neurodegenerative
cancers,
metabolic
cardiovascular
diseases.
This
review
aims
at
systematically
comprehensively
introducing
its
role
various
while
unravelling
molecular
mechanisms
By
providing
theoretical
basis
development
related
small-molecule
drugs
as
well
treating
this
seeks
to
contribute
understanding
therapeutic
potential.
review,
we
introduce
dissect
major
categories
been
discovered.
We
also
focus
recent
advances
underlying
both
classical
non-classical
Moreover,
current
situation
targeting
different
types
further
summarized,
valuable
insights
into
discovery
more
candidate
future.
On
other
hand,
reveal
clinically
relevant
implementations
are
potentially
autophagy,
such
predictive
approaches
treatments
tailored
individual
patients.
The EPMA Journal,
Journal Year:
2024,
Volume and Issue:
15(2), P. 149 - 162
Published: May 11, 2024
Abstract
Non-communicable
chronic
diseases
(NCDs)
have
become
a
major
global
health
concern.
They
constitute
the
leading
cause
of
disabilities,
increased
morbidity,
mortality,
and
socio-economic
disasters
worldwide.
Medical
condition-specific
digital
biomarker
(DB)
panels
emerged
as
valuable
tools
to
manage
NCDs.
DBs
refer
measurable
quantifiable
physiological,
behavioral,
environmental
parameters
collected
for
an
individual
through
innovative
technologies,
including
wearables,
smart
devices,
medical
sensors.
By
leveraging
healthcare
providers
can
gather
real-time
data
insights,
enabling
them
deliver
more
proactive
tailored
interventions
individuals
at
risk
patients
diagnosed
with
Continuous
monitoring
relevant
wearable
devices
or
smartphone
applications
allows
clinicians
track
progression
NCDs
in
real
time.
With
introduction
(DBM),
new
quality
primary
secondary
is
being
offered
promising
opportunities
assessment
protection
against
health-to-disease
transitions
vulnerable
sub-populations.
DBM
enables
take
most
cost-effective
targeted
preventive
measures,
detect
disease
developments
early,
introduce
personalized
interventions.
Consequently,
they
benefit
life
(QoL)
affected
individuals,
economy,
society
large.
instrumental
paradigm
shift
from
reactive
services
3PM
approach
promoted
by
European
Association
Predictive,
Preventive,
Personalized
Medicine
(EPMA)
involving
experts
55
countries
This
position
manuscript
consolidates
multi-professional
expertise
area,
demonstrating
clinically
examples
providing
roadmap
implementing
concepts
facilitated
DBs.
The EPMA Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 14, 2025
Association
of
both
intrinsic
and
extrinsic
risk
factors
leading
to
accelerated
skin
ageing
is
reflected
in
excessive
ROS
production
ir/reversible
mitochondrial
injury
burnout,
as
abundantly
demonstrated
by
accumulating
research
data.
Due
the
critical
role
stress
pathophysiology
disorders,
maintained
(primary
care)
restored
(secondary
health,
rejuvenation
homoeostasis
are
considered
most
effective
holistic
approach
advance
dermatological
treatments
based
on
systemic
health-supportive
stimulating
measures.
Per
evidence,
an
anti-ageing
protection,
wound
healing
scarring
quality
-
all
strongly
depend
sustainable
functionality
well-balanced
homoeostasis.
The
latter
can
be
objectively
measured
and,
if
necessary,
a
manner
pre-
rehabilitation
algorithms
tailored
individualised
patient
profiles.
entire
spectrum
corresponding
innovations
area
includes
natural
rejuvenation,
aesthetic
reconstructive
medicine,
protection
targeted
disorders.
Contextually,
mitochondria-centric
dermatology
instrumental
for
advanced
3PM-guided
which
makes
good
use
predictive
multi-level
diagnostics
against
health-to-disease
transition
progression
relevant
Cost-effective
new
treatment
avenues
focused
health
physiologic
proposed
article
including
in-depth
analysis
cases
exemplified
care
with
detailed
mechanisms
expert
recommendations
presented.
The EPMA Journal,
Journal Year:
2024,
Volume and Issue:
15(3), P. 415 - 452
Published: Aug. 29, 2024
Because
of
its
rapid
progression
and
frequently
poor
prognosis,
stroke
is
the
third
major
cause
death
in
Europe
first
one
China.
Many
independent
studies
demonstrated
sufficient
space
for
prevention
interventions
primary
care
ischemic
defined
as
most
cost-effective
protection
vulnerable
subpopulations
against
health-to-disease
transition.
Although
several
identified
molecular
patterns
specific
IS
body
fluids,
none
these
approaches
has
yet
been
incorporated
into
treatment
guidelines.
The
advantages
disadvantages
individual
fluids
are
thoroughly
analyzed
throughout
paper.
For
example,
multiomics
based
on
a
minimally
invasive
approach
utilizing
blood
components
recommended
real-time
monitoring,
due
to
particularly
high
level
dynamics
system.
On
other
hand,
tear
fluid
more
stable
system
non-invasive
patient-friendly
holistic
appropriate
health
risk
assessment
innovative
screening
programs
management.
This
article
details
aspects
essential
promote
practical
implementation
highlighted
achievements
3PM-guided
The EPMA Journal,
Journal Year:
2024,
Volume and Issue:
15(4), P. 559 - 571
Published: Nov. 20, 2024
Breast
cancer
belongs
to
the
most
commonly
diagnosed
malignancies
worldwide,
with
its
increasing
incidence
paralleled
by
advances
in
early
diagnostics
and
effective
treatments
resulting
significantly
improved
survival
rates.
However,
breast
survivors
often
experience
reduced
quality
of
life
linked
long-term
health
burden
as
a
consequence
aggressive
oncological
applied.
Their
frequently
recorded
complains
include
chronic
fatigue,
physical
activity,
disordered
sleep,
chronification
pain,
severe
mental
impairments-all
per
evidence
are
associated
compromised
mitochondrial
impaired
homeostasis.
Self-report
survivor
is
included
this
article
illustrate
currently
uncovered
patient
needs.
This
highlights
mechanisms
behind
suboptimal
damage,
introduces
novel,
mitochondria-based
holistic
approach
addressing
rehabilitation
concepts
for
following
advanced
principles
predictive,
preventive
personalised
medicine
(3PM).
By
operating
via
function,
proposed
triggers
systemic
effects
at
molecular,
sub/cellular
organismal
levels
positively
affecting
energy
metabolism,
repair
well
creating,
therefore,
highly
algorithms
tailored
an
individualised
profile.
The
methodology
integrates
assessments
utilising
homeostasis
biomarkers
tear
fluid
non-invasive
diagnostic
tool,
nutraceuticals
lifestyle
adjustments.
introduced
aligns
3PM,
offering
proactive
framework
managing
persistent
post-treatment
symptoms
cohort
survivors.
Furthermore,
presented
also
applicable
pre-habilitation
programmes
considering
needs
other
cohorts
affected
diseases
such
CVD
orthopaedic
disorders
planned
major
surgical
incisions,
who
require
individually
adapted
pre-
programmes.
Implementing
innovative
strategies
may
lead
full
recovery,
sustainable
conditions
and,
facilitating
patients'
comeback
normal
daily
activities,
family
professional
life.
Contextually,
considered
'proof-of-principle'
model
3PM-related
paradigm
shift
from
reactive
cost-effective
management
both
primary
secondary
care
benefiting
large
spectrum
cohorts,
individuals
society
large.
The EPMA Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 31, 2025
Metabolomics
measurements
of
eccrine
sweat
may
provide
novel
and
relevant
biomedical
information
to
support
predictive,
preventive
personalised
medicine
(3PM).
However,
only
limited
data
is
available
regarding
metabolic
alterations
accompanying
chemotherapy
breast
cancer
patients
related
residual
burden
(RCB)
or
therapy
response.
Here,
we
have
applied
Metabo-Tip,
a
non-invasive
metabolomics
assay
based
on
the
analysis
from
fingertips,
investigate
feasibility
such
an
approach,
especially
with
respect
drug
monitoring,
assessing
lifestyle
parameters
stratification
patients.
Eccrine
samples
were
collected
(n
=
9)
during
first
cycle
neoadjuvant
at
four
time
points
in
this
proof-of-concept
study
Tertiary
University
Hospital.
Metabolites
analysed
using
mass
spectrometry.
Blood
plasma
same
timepoints
also
validated
targeted
kit,
addition
proteomics
fatty
acids/oxylipin
analysis.
A
total
247
exogenous
small
molecules
endogenous
metabolites
identified
Cyclophosphamide
ondansetron
successfully
detected
monitored
individual
accurately
reflected
administration
schedule.
The
non-essential
amino
acids
asparagine,
serine
proline,
as
well
ornithine
significantly
regulated
blood
over
cycle.
their
distinct
time-dependent
profiles
indicated
compartment-specific
distributions.
Indeed,
metabolite
composition
seems
largely
resemble
interstitial
fluid.
Plasma
proteins
acids/oxylipins
not
affected
by
treatment
Individual
smoking
habit
was
revealed
simultaneous
detection
nicotine
its
primary
cotinine
sweat.
Stratification
according
RCB
pronounced
differences
these
baseline,
e.g.,
essential
acids,
possibly
due
systemic
contribution
impact
turnover.
Mass
spectrometry-based
qualified
for
risk
assessment
allowed
us
monitor
response
therapy.
Moreover,
potentially
predictive
pattern
stratifying
extent
activity
tissue
baseline.
derived
otherwise
hardly
accessible
fluid
and,
thus,
opens
up
new
dimension
biomonitoring
secondary
tertiary
care.
simple
sample
collection
without
need
trained
personnel
could
enable
decentralised
long-term
assess
stable
disease
progression.
indeed
advance
3PM
benefit
online
version
contains
supplementary
material
10.1007/s13167-025-00396-6.